Company Filing History:
1 out of 75 
1 out of 5,312 
Years Active: 2025
Title: Innovations in Cardiac Treatment by Inventor Han Sun
Introduction
Han Sun is a notable inventor based in Mountain View, CA, who has made significant contributions to the field of cardiac treatment. He holds a patent that addresses heart conditions associated with RBM20 deficiency, showcasing his expertise in genetic screening and disease modeling.
Latest Patents
Han Sun's patent, titled "Methods of treatment, genetic screening, and disease models for heart conditions associated with RBM20 deficiency," presents innovative methods for treating heart conditions linked to RBM20 deficiency. This includes RBM20-dependent dilated cardiomyopathy and heart failure, utilizing compounds that enhance the expression of RBM20, such as all-trans retinoic acid. The patent also outlines genetic screening methods to identify individuals with a P633L mutation in RBM20, which indicates a genetic predisposition to developing RBM20-dependent dilated cardiomyopathy. Furthermore, the patent discusses the use of induced pluripotent stem cell-derived cardiomyocytes (IPSC-CMs) for therapeutic screening.
Career Highlights
Throughout his career, Han Sun has worked with prestigious institutions, including the European Molecular Biology Laboratory and Leland Stanford Junior University. His work has significantly advanced the understanding and treatment of heart conditions, particularly those related to genetic factors.
Collaborations
Han Sun has collaborated with esteemed colleagues, including Francesca Briganti and Lars Steinmetz, contributing to a rich exchange of ideas and research in the field of cardiac health.
Conclusion
Han Sun's innovative work in cardiac treatment and genetic screening represents a significant advancement in medical science. His contributions are paving the way for new therapeutic approaches to heart conditions associated with genetic predispositions.